Patents by Inventor Yu-Wei Chiang

Yu-Wei Chiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for the treatment of canine influenza virus disease
    Publication number: 20070092537
    Abstract: Compositions, including vaccine compositions, and methods for treating, preventing or ameliorating canine influenza virus (CIV) disease by utilizing one or more canine influenza virus (CIV) or equine influenza virus (EIV) strain or immunogens thereof are set forth herein. Also set forth are challenge models useful in assessing the efficacy of a composition against canine influenza virus, comprising an equine influenza virus (EIV) or canine influenza virus (CIV) strain or immunogens thereof.
    Type: Application
    Filed: October 18, 2006
    Publication date: April 26, 2007
    Applicant: Wyeth
    Inventors: Yu-Wei Chiang, Hsien-Jue Chu, Michael Gill, Kim Gugisberg
  • Use of DNA vaccine in combination with a conventional vaccine to overcome immunogen interference
    Publication number: 20060222660
    Abstract: A method, composition and kit for reducing or preventing immunogenic interference in a multi-valent vaccine utilizes a nucleic acid or DNA component along with other non-nucleic acid immunogenic components.
    Type: Application
    Filed: March 28, 2006
    Publication date: October 5, 2006
    Applicant: Wyeth
    Inventors: Hsien-Jue Chu, Yu-Wei Chiang, Terry Ng
  • Canine vaccine for protection against ehrlichiosis
    Publication number: 20060188524
    Abstract: The present invention provides a safe and effective vaccine composition which comprises: an effective immunizing amount of an inactivated Ehrlichia canis bacterin; a pharmacologically acceptable carrier; and an immunogenically stimulating amount of an adjuvant system consisting essentially of an antibody response inducing agent and a cell-mediated immunity response inducing agent. The present invention also provides a method for the prevention or amelioration of canine ehrlichiosis in dogs.
    Type: Application
    Filed: April 20, 2006
    Publication date: August 24, 2006
    Applicant: Wyeth
    Inventors: Liangbiao Hu, Thomas Hess, Yu-Wei Chiang, Hsien-Jue Chu
  • Canine vaccine for protection against ehrlichiosis
    Publication number: 20050202046
    Abstract: The present invention provides a safe and effective vaccine composition which comprises: an effective immunizing amount of an inactivated Ehrlichia canis bacterin; a pharmacologically acceptable carrier; and an immunogenically stimulating amount of an adjuvant system consisting essentially of an antibody response inducing agent and a cell-mediated immunity response inducing agent. The present invention also provides a method for the prevention or amelioration of canine ehrlichiosis in dogs.
    Type: Application
    Filed: March 9, 2005
    Publication date: September 15, 2005
    Applicant: Wyeth
    Inventors: Liangbiao (George) Hu, Thomas Hess, Yu-Wei Chiang, Hsien-Jue (Steve) Chu
  • Vaccines for counteracting inhibition of neutrophil degranulation
    Patent number: 4701323
    Abstract: Vaccines for counteracting inhibition of neutrophil degranulation by pathogenic cellular microorganisms comprise one or more purines conjugated to antigenic carriers. The purines include adenine and/or guanine in the form of a base, nucleoside, or nucleotide. The vaccines can be used with cattle to increase resistance to infections by Brucella abortus (brucellosis) and/or Haemophilus somnus (thromboembolic meningoencephalitis) and related symptomatic complex.
    Type: Grant
    Filed: October 23, 1985
    Date of Patent: October 20, 1987
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: James A. Roth, Peter C. Canning, Yu-Wei Chiang